MedPath

Transdiagnostic Group Intervention for Children With Behavior Problems

Not Applicable
Completed
Conditions
Behavioral Symptoms
Emotional Disturbances
Interventions
Behavioral: Group Therapy
Registration Number
NCT02794051
Lead Sponsor
University of Colorado, Denver
Brief Summary

This study fills a notable gap in the transdiagnostic literature by evaluating whether an evidence-based transdiagnostic treatment for emotional disorders such as the Unified Protocol for Children (UP-C) is effective for treating childhood behavior problems.

Detailed Description

By participating in the study, child participants will learn emotion regulation skills and have opportunities to interact and practice skills with other children who have similar problems. In addition, parent participants will learn effective parenting skills, including appropriate limit-setting, use of praise and consequences, and empathy, that may help them effectively navigate the challenges of caring for a child with behavior concerns (1). Parents will also have the opportunity to interact with other parents who face similar challenges, providing validation and support. Upon completion of the study, investigators plan to share these findings at professional conferences and submit manuscripts to peer-reviewed journals. Collectively, this study will add to the literature in the pediatric mental health field and may also serve as a model for other outpatient clinics regarding implementation and provision of a transdiagnostic approach to treat children with behavior problems. Thus, the main goals of the current study are to examine the effectiveness of the UP-C group treatment in reducing childhood behavior problems, evaluate parents' satisfaction with this treatment, and determine the feasibility of implementing this treatment in a pediatric outpatient setting.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
8
Inclusion Criteria
  • Ages 8 - 12 years
  • English speaking
  • Primary Behavior Disorder
  • At least 1 English-speaking parent/legal guardian who can provide informed consent for the child
  • Parent/Legal Guardian must agree to participate in the Trial
Exclusion Criteria
  • Child is: a ward of the state

  • has active suicidal ideation

  • has homicidal ideation

  • has self-harm behaviors

  • has an intellectual disability

  • has a pervasive developmental disability or significant developmental delay

  • has an active substance use disorder

  • is currently participating in individual or group psychotherapy, or

  • has participated in therapy within the past year

  • has a sibling that is also enrolled in the study

  • Parents/Legal Guardians that:

    1. are unwilling to participate in the study
    2. are non-English speaking
    3. have an intellectual disability
    4. have a pervasive developmental disability or
    5. a significant developmental delay
    6. do not have legal custody of the child participant
    7. do not reside in the same home as the child participant

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Unified Protocol for ChildrenGroup TherapyChild participants with behavior problems between the ages of 8-12 and their caregivers will participate in a transdiagnostic group therapy protocol.
Primary Outcome Measures
NameTimeMethod
Change in rates of noncompliance, tantruming, and parenting practices on the Home Record Card12 weeks - Measured daily from baseline to post-treatment

Chart for recording events of noncompliance, tantrums, and parenting practices.

Secondary Outcome Measures
NameTimeMethod
Parents' satisfaction with treatment, as measured by the Family Satisfaction Survey10 weeks - Measured at weeks 3, 7, and 10.

To assess parents' satisfaction with their participation in the UP-C intervention.

Treatment feasibility, as measured by the Family Satisfaction Survey and attendance rates10 weeks

To evaluate parents' opinions about whether participation in a 10-week therapy group treatment is feasible and whether the interventions taught are feasible.

Change in pre- vs. post-treatment scores on the Transdiagnostic Questionnaires for Parent and Child10 weeks - Measured at Week 1 (pre-treatment) and at Week 10 (post-treatment)

Measures several transdiagnostic mechanisms including child emotional and behavioral symptoms, sleeping difficulties, and parenting practices.

Change in pre- vs. post-treatment scores on the Eyberg Child Behavior Inventory10 weeks - Measured at Week 1 (pre-treatment) and at Week 10 (post-treatment)

Measures intensity of behavior related problems and degree to which these behaviors are viewed as problematic by parents.

Change in pre- vs. post-treatment scores on the Achenbach Rating Scales (Child Behavior Checklist and Youth Self-Report)10 weeks - Measured at Week 1 (pre-treatment) and at Week 10 (post-treatment)

Measures parent and child report of the presence of child behavior and emotional problems

Change in pre- vs. post-treatment scores on the Alabama Parenting Questionnaire10 weeks - Measured at Week 1 (pre-treatment) and at Week 10 (post-treatment)

Measures five dimensions of parenting: positive involvement, supervision, positive discipline techniques, consistency in disciplining, and use of corporal punishment.

Trial Locations

Locations (1)

Children's Hospital Colorado

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath